Table 3.

Correlation between FasL Expression and Pathological Tumor Stage

Stage	n	%*
Ta, T1†	23	13
T2 to T4‡	21	81

*Percentage of tissue samples positive for FasL by immunostaining.

^†Ta, T1 are superficial TCCs.

^‡T2 to T4 are invasive TCCs; P < 0.0001.